目前,全球非常重视鲍曼不动杆菌所引发的感染问题。鲍曼不动杆菌的药物主动外排泵与外膜通透屏障会产生协同作用,促使其天然多重耐药性呈现出来。虽然临床可采用多黏菌素E、含舒巴坦复合制剂、碳青霉烯类等药物或联合使用抗生素进行治疗,不过鲍曼不动杆菌感染,但是因其具有多重耐药性,以至于在用药过程中,医护人员需对药物疗效密切观察,并对相关药物敏感试验结果进行参考,适度调整用药方案。 At present, the world attaches great importance to the Acinetobacter baumannii infection caused. Acinetobacter baumannii drugs active efflux pumps and membrane permeability barrier will have a synergistic effect, prompting its natural multi-drug resistance emerged. Although clinical use of polymyxin E, sulbactam combination agents, carbapenems and other drugs or combined antibiotics for treatment, but Acinetobacter baumannii infection, but because of its multi-drug resistance, so that In the course of medication, health care workers need to be closely observed on the efficacy of drugs, and related drug sensitivity test results for reference, moderate adjustment medication program.